Skip to content

ENDOCURE

Active Private limited companyfounded 2022active for 4 yearsDageraadlaan 32, 1652 BeerselKBO/BCE: BE 0786.853.211
ENDOCURE
Follow ReportCompare

Board

1 director, since incorporation
Director
since 07-06-2022 term without a fixed end
listed in the 2025 annual accounts, filed on 31-08-2026
Signing authorityThe articles say who may bind the company, for example by signing a contract.
Each director alone
deed of 11-05-2026

Office holders in the KBO →

Mandates through the years

1 name, the dashed line is today

Director
Board
Mandates as a list
    • Director, from 07-06-2022 to date

Control

Founder
This company
ENDOCURE
Equity €239,878
Profit €125,992 in 2025

Capital

Contribution
€4,000
Shares
100
Contribution per share
€40
Equity per share
€2,399 in 2025
Source
deed of 09-06-2022

Articles of association

deed of 11-05-2026 (in French)
DurationMost companies exist for an unlimited period, until they are dissolved.
Unlimited
Transfer restrictionThis rule says whether shareholders may sell their shares freely or need approval first.
“Procedure- en expertisekosten voor helft ten laste overdrager en helft ten laste koper(s) naar evenredigheid verworven aantal bij meerdere…”
Annual meetingThe shareholders approve the annual accounts, among other things, at the annual meeting.
First Saturday of June at 14:00

Shareholders

At incorporation deed of 09-06-2022 ↗
  • 100 shares (100%) · €4,000 in cash

Capital transactions

Capital over time
  1. 11-05-2026 Capital stated in the deed · 100 shares
  2. 09-06-2022 Incorporation · €4,000 · 100 shares

Next steps

See this company's board, registered office and name on a given date.Company as of a date See what became of the directors' other companies.Supplier due diligence Check whether you can accept this company as a client under the anti-money-laundering law.AML client file

We would like to set cookies. That happens only with your consent. What we measure